dc.contributor.author | Creagh, Emma | en |
dc.date.accessioned | 2019-09-11T14:24:50Z | |
dc.date.available | 2019-09-11T14:24:50Z | |
dc.date.issued | 2019 | en |
dc.date.submitted | 2019 | en |
dc.identifier.citation | Kufer, T.A., Creagh, E.M. & Bryant C., Guardians of the Cell: Effector-Triggered Immunity Steers Mammalian Immune Defense, Trends in Immunology, 11, 10, 2019 | en |
dc.identifier.issn | 1471-4906 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description | DOI: 10.1016/j.it.2019.08.001 | en |
dc.description.abstract | The mammalian innate immune system deals with invading pathogens and stress by activating pattern-recognition receptors (PRRs) in the host. Initially proposed to be triggered by the discrimination of defined molecular signatures from pathogens rather than from self, it is now clear that PRRs can also be activated by endogenous ligands, bacterial metabolites and, following pathogen-induced alterations of cellular processes, changes in the F-actin cytoskeleton. These processes are collectively referred to as effector-triggered immunity (ETI). Here, we summarize the molecular and conceptual advances in our understanding of cell autonomous innate immune responses against bacterial pathogens, and discuss how classical activation of PRRs and ETI interplay to drive inflammatory responses. | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Trends in Immunology | en |
dc.relation.ispartofseries | 11 | en |
dc.relation.ispartofseries | 10 | en |
dc.rights | Y | en |
dc.subject | Innate immunity | en |
dc.subject | Effector-triggered immunity | en |
dc.subject | PAMP-triggered immunity | en |
dc.subject | Cytoskeleton | en |
dc.subject | Bacteria | en |
dc.subject | Pathogens | en |
dc.title | Guardians of the Cell: Effector-Triggered Immunity Steers Mammalian Immune Defense | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/ecreagh | en |
dc.identifier.rssinternalid | 206796 | en |
dc.identifier.doi | https://doi.org/10.1016/j.it.2019.08.001 | en |
dc.rights.ecaccessrights | openAccess | |
dc.subject.TCDTheme | Immunology, Inflammation & Infection | en |
dc.subject.TCDTag | EXPERIMENTAL INFECTIONS | en |
dc.subject.TCDTag | IL-1, Toll Receptors, NF-KappaB | en |
dc.subject.TCDTag | INFLAMMATION | en |
dc.subject.TCDTag | Infection and immunity | en |
dc.subject.TCDTag | Molecular basis to inflammation and innate immunity | en |
dc.subject.TCDTag | Nod-like receptors | en |
dc.subject.TCDTag | Toll-Like Receptors | en |
dc.subject.TCDTag | in vitro models of infection | en |
dc.identifier.orcid_id | 0000-0001-7631-4370 | en |
dc.subject.darat_thematic | Health | en |
dc.status.accessible | N | en |
dc.contributor.sponsor | Irish Research Council (IRC) | en |
dc.contributor.sponsorGrantNumber | GOIPG/2018/3407 | en |
dc.contributor.sponsor | Science Foundation Ireland (SFI) | en |
dc.contributor.sponsorGrantNumber | 16/TIDA/4004 | en |
dc.identifier.uri | https://www.cell.com/trends/immunology/fulltext/S1471-4906(19)30168-1?rss=yes | |
dc.identifier.uri | http://hdl.handle.net/2262/89480 | |